ExcelFin Acquisition Corp Completes Business Combination With Baird Medical Investment Holdings Limited

ENDYMED Merges with Majority Shareholder Shanghai Haohai Biological Technology

March 6, 2025

Medical Devices

ENDYMED Ltd completed a full merger with its majority shareholder and China distributor, Shanghai Haohai Biological Technology Co., Ltd, consolidating ownership and operations. The deal is intended to strengthen ENDYMED’s presence in China, streamline the global supply chain, accelerate innovation, and enhance the company’s global market competitiveness.

Mana Capital Acquisition Corp. Completes Business Combination with Cardio Diagnostics (Cardio Diagnostics Holdings, Inc.)

October 26, 2022

Biotechnology

Mana Capital Acquisition Corp. completed its business combination with Cardio Diagnostics, resulting in Cardio Diagnostics Holdings, Inc. being listed on Nasdaq under ticker CDIO (common stock) and CDIOW (warrants). The deal had been supported by a previously announced definitive merger agreement dated May 27, 2022 and required multiple extensions to complete before closing.

Excelera to Become Publicly Traded via Merger with Future Health ESG Corp

June 14, 2022

Healthcare Services

Excelera DCE entered into a definitive business combination agreement with Future Health ESG Corp. (NASDAQ: FHLT), a special purpose acquisition company, to create a combined public company expected to operate as Excelera Health, Inc. The transaction is valued at an initial enterprise value of approximately $459 million and is expected to fund expansion of Excelera’s Medicare value-based care platform into additional geographies.

Boston Scientific Acquires Baylis Medical Company Inc.

October 6, 2021

Medical Devices

Boston Scientific Corporation entered into a definitive agreement to acquire Baylis Medical Company Inc. for an upfront payment of $1.75 billion, subject to closing adjustments. The acquisition is expected to expand Boston Scientific’s electrophysiology and structural heart portfolios by adding the RF NRG and VersaCross transseptal platforms and related guidewires, sheaths, and dilators.

Baird Capital Invests in Upfront Healthcare

November 17, 2020

Healthcare Services

Baird Capital has made a growth capital investment in Upfront Healthcare, a Chicago-based omnichannel patient engagement and communication platform founded in 2016. The investment is intended to support Upfront's continued growth and capability expansion to help health systems improve patient engagement and care delivery.

Baird Capital Invests in eCube Solutions

August 20, 2020

Aerospace & Defense

Baird Capital, the direct investment arm of Robert W. Baird & Co., has acquired an interest in eCube Solutions Limited, a UK-based provider of aircraft storage, disassembly and parts re-use and recycling services. The investment will fund expansion of eCube's UK operations, accelerate growth at its new continental European facility in Spain, expand parking and disassembly capacity, and support entry into the North American market.